Follow the IMMURON LIMITED stock price and the full insider trade history of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €11m. The latest transaction was reported on 15 July 2026 (Change in Substantial Holding). Among the most active insiders: listed in Annexure A (Group Entity),(together BNY Group). The full history is free.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IMMURON LIMITED es una empresa que cotiza en la Bolsa de Valores de Australia, centrada en el desarrollo de tratamientos para enfermedades intestinales. La empresa enfatiza la investigación y la innovación en el sector de la salud.